| ASSET | YEAR | % RETURN |
|---|---|---|
AXT (AXTI) | 2026 | 718.78% |
MaxLinear (MXL) | 2026 | 456.14% |
Aehr Test Systems (AEHR) | 2026 | 352.05% |
Navitas Semiconductor (NVTS) | 2026 | 290% |
P3 Health Partners (PIII) | 2026 | 272.88% |
Ichor (ICHR) | 2026 | 259.35% |
Immunitybio (IBRX) | 2026 | 257.43% |
Ultra Clean (UCTT) | 2026 | 221.38% |
Vishay Intertechnology (VSH) | 2026 | 220.44% |
Erasca (ERAS) | 2026 | 202.96% |
Veradermics (MANE) | 2026 | 198.88% |
Silicon Motion Technology (SIMO) | 2026 | 193.77% |
Babcock & Wilcox Enterprises (BW) | 2026 | 192.92% |
Iridium Communications (IRDM) | 2026 | 180.46% |
Enliven Therapeutics (ELVN) | 2026 | 168% |
Penguin Solutions (PENG) | 2026 | 167.66% |
Himax Technologies (HIMX) | 2026 | 154.41% |
Tango Therapeutics (TNGX) | 2026 | 128.7% |
Intuitive Machines (LUNR) | 2026 | 128.15% |
Spyre Therapeutics (SYRE) | 2026 | 126.04% |
Alumis (ALMS) | 2026 | 125.38% |
Kulicke and Soffa Industries (KLIC) | 2026 | 123.73% |
Redwire (RDW) | 2026 | 120.83% |
Maase (MAAS) | 2026 | 119.44% |
POET Technologies (POET) | 2026 | 119.07% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.